Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€19.34

€19.34

-0.870%
-0.17
-0.870%
-
 
11:34 / Tradegate WKN: A14RPH / Name: Chemours / Stock / Chemicals / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Financial data and news for Chemours

sharewise wants to provide you with the best news and tools for Chemours, so we directly link to the best financial data sources.

News

Chemours Q1 Earnings Call Highlights
Chemours Q1 Earnings Call Highlights

Chemours (NYSE:CC) said it opened 2026 with first-quarter results that were “well above earnings expectations,” driven by strong execution in

Alta Fundamental Dumps 175K Chemours Shares in Q1: https://cdn.content.foolcdn.com/images/1umn9qeh/production/0fe050b5d35dffd742b195c313bda291f30dfea0-1401x1251.png?w=800&q=75&fit=max&auto=format
Alta Fundamental Dumps 175K Chemours Shares in Q1

Alta Fundamental Advisers LLC cut its stake in Chemours (NYSE:CC) by 175,000 shares during the first quarter, an estimated $3.05 million trade based on quarterly average pricing, according to an SEC

Why Chemours Plunged Today
Why Chemours Plunged Today

Shares of European chemicals company Chemours (NYSE: CC) fell 16.8% on Friday, as of 2:46 p.m. EDT.

The chemicals giant reported lackluster earnings today and also provided guidance that merely met

This Chemicals Stock Is Down 32% but Just Became a Top 5 Holding After One Fund's $13 Million Bet
This Chemicals Stock Is Down 32% but Just Became a Top 5 Holding After One Fund's $13 Million Bet

New York City-based Alta Fundamental Advisers initiated a new position in The Chemours Company (NYSE:CC), acquiring 800,000 shares valued at an estimated $12.67 million, according to a November 13